Biomea Fusion, Inc. Shareholders' Equity
Biomea Fusion, Inc. (BMEA) had Shareholders' Equity of $12.14 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.14M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $18.72M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $29.55M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $15.62M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $12.14M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $18.72M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $29.55M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $15.62M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $27.51M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $28.74M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $51.57M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $75.97M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $103.95M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $135.31M 10-Q · filed 2025-11-04 |
| 2023-12-31 | $169.24M 10-K · filed 2026-03-24 |
| 2023-09-30 | $199.61M 10-Q · filed 2024-10-29 |
| 2023-06-30 | $224.31M 10-Q · filed 2024-10-29 |
| 2023-03-31 | $83.13M 10-Q · filed 2024-10-29 |
| 2022-12-31 | $108.54M 10-K · filed 2026-03-24 |
| 2022-09-30 | $130.63M 10-Q · filed 2023-10-30 |
| 2022-06-30 | $150.39M 10-Q · filed 2023-10-30 |
| 2022-03-31 | $164.76M 10-Q · filed 2023-10-30 |
| 2021-12-31 | $178.78M 10-K · filed 2025-03-31 |
| 2021-09-30 | $191.33M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $202.02M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $221.00K 10-Q · filed 2022-11-07 |
| 2020-12-31 | $5.17M 10-K · filed 2024-03-28 |
| 2020-09-30 | $7.70M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $8.83M 10-Q · filed 2021-11-03 |
| 2020-03-31 | -$369.00K 10-Q · filed 2021-11-03 |
| 2019-12-31 | -$21.00K 10-K · filed 2023-03-28 |
| 2018-12-31 | -$263.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |